|
Volumn 61, Issue 3, 2001, Pages 931-934
|
MS-275, a histone deacetylase inhibitor, selectively induces transforming growth factor β type II receptor expression in human breast cancer cells
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HISTONE DEACETYLASE INHIBITOR;
N (2 AMINOPHENYL) 4 (3 PYRIDINYLMETHOXYCARBONYLAMINOMETHYL)BENZAMIDE;
TRANSFORMING GROWTH FACTOR BETA RECEPTOR;
TRANSFORMING GROWTH FACTOR BETA2 RECEPTOR;
UNCLASSIFIED DRUG;
ACETYLATION;
ARTICLE;
BREAST CANCER;
CANCER INHIBITION;
FEMALE;
HUMAN;
HUMAN CELL;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
SIGNAL TRANSDUCTION;
TRANSCRIPTION REGULATION;
ACETYLATION;
ANTINEOPLASTIC AGENTS;
BENZAMIDES;
BREAST NEOPLASMS;
CELL DIVISION;
CHROMATIN;
ENZYME INHIBITORS;
GENE EXPRESSION;
GROWTH INHIBITORS;
HISTONE DEACETYLASES;
HISTONES;
HUMANS;
PLASMINOGEN ACTIVATOR INHIBITOR 1;
PYRIDINES;
RECEPTORS, TRANSFORMING GROWTH FACTOR BETA;
RNA, MESSENGER;
SIGNAL TRANSDUCTION;
TRANSFORMING GROWTH FACTOR BETA;
TUMOR CELLS, CULTURED;
|
EID: 0035113602
PISSN: 00085472
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (108)
|
References (27)
|